MedPath
HSA Approval

Carvedilol Sandoz 25mg

SIN13156P

Carvedilol Sandoz 25mg

Carvedilol Sandoz 25mg

November 7, 2005

NOVARTIS (SINGAPORE) PTE LTD

SANDOZ SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantNOVARTIS (SINGAPORE) PTE LTD
Licence HolderSANDOZ SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C07AG02

carvedilol

Manufacturer Information

SANDOZ SINGAPORE PTE. LTD.

Salutas Pharma GmbH

Active Ingredients

Carvedilol

25.0 mg

Carvedilol

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Carvedilol Sandoz 25mg - HSA Approval | MedPath